Parse Biosciences · 6 hours ago
Sales Development Representative, Central US
United States
Full-time
Remote
New Grad, Entry LevelParse Biosciences is a global life sciences company committed to advancing human health and scientific research. They are seeking a Sales Development Representative to engage with potential customers, generate leads, and support the sales strategy across various sectors including academia and biotechnology.
BioinformaticsBiotechnologyGeneticsLife Science
Responsibilities
Be responsible for achieving sales objectives across a geography, developing new business, and generating potential customer leads at new accounts who have an interest in our single cell RNA sequencing products
Generate and manage a high volume of calls and zoom meetings (target of 30 calls per day)
Become an expert in using lead development software, specifically LinkedIn Navigator, Crunchbase, and SciLeads
Maintain a CRM process that include calls and conversation notes
Be skilled and consistent with research and follow-up
Effectively communicate value proposition and technical advantages to customers
Continually develop technical knowledge related to new, emerging, and related single cell research
Display a high degree of professionalism both internally and externally
Qualification
Required
A minimum of a Bachelor's in biology/genomics or a related field
Strong desire to develop a career in life science sales
Previous molecular biology lab experience
Excellent communication skills - written & verbal, including phone communication skills
Self-motivation and a strong ability to work autonomously and effectively manage tasks and goals without constant supervision
Having a home office within the Central US Time Zone
Company
Parse Biosciences
Parse Biosciences is a biotechnology startup company that develops single-cell sequencing kit solutions for researchers.
Founded in 2018
51-200 employees
Funding
Current Stage
Growth StageTotal Funding
$99.96MKey Investors
Soleus CapitalHorizon Technology FinanceBioeconomy Capital
2025-11-04Acquired
2023-12-14Series C· $50M
2023-12-14Debt Financing
Leadership Team
Alex Rosenberg
Cofounder and CEO
Charles Roco
Co-Founder and CTO
Recent News
2026-01-22
2026-01-22
Company data provided by crunchbase